(2R,3aS,8aR)‐2‐(4‐Methoxy­phen­yl)‐3,3a,8,8a‐tetra­hydro‐2H‐indeno[1,2‐d]oxazole

By  

Acta Crystallographica Section E, Vol. 63, Iss. 2, 2007-02 ,pp. : o420-o421

John Wiley & Sons Inc

Access to resources Recommend Favorite

(3aR,8bR)‐(+)‐1‐Methyl‐1,2,3,3a,4,8b‐hexa­hydro­pyrrolo[2′,3′:3,4]cyclo­penta[1,2‐b]pyridine‐1,5‐diium dichloride monohydrate

By  

Acta Crystallographica Section E, Vol. 62, Iss. 7, 2006-07 ,pp. : o2958-o2960

John Wiley & Sons Inc

Access to resources Recommend Favorite

(1aR,2aS,5aS,5bS)‐Perhydro‐4H‐oxireno[3,4]cyclo­penta­[1,2‐b]furan‐4‐one

By  

Acta Crystallographica Section E, Vol. 63, Iss. 3, 2007-03 ,pp. : o1359-o1360

John Wiley & Sons Inc

Access to resources Recommend Favorite

4‐Chloro‐2‐{[(R)‐(3′S,8′R)‐3,3a,8,8a‐tetra­hydro‐2H‐indeno[1,2‐d][1,3]oxazol‐3‐yl](phen­yl)meth­yl}phenol

By  

Acta Crystallographica Section E, Vol. 62, Iss. 9, 2006-09 ,pp. : o4078-o4079

John Wiley & Sons Inc

Access to resources Recommend Favorite

(3R,4R)‐(–)‐3‐Hydroxy­methyl‐4‐phenyl‐2‐o‐toluoyl‐1,2,3,4‐tetra­hydro­isoquinoline

By  

Acta Crystallographica Section E, Vol. 62, Iss. 5, 2006-05 ,pp. : o1774-o1776

John Wiley & Sons Inc

Access to resources Recommend Favorite